Correlation Between Madrigal Pharmaceuticals and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Myriad Genetics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Myriad Genetics.

Diversification Opportunities for Madrigal Pharmaceuticals and Myriad Genetics

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Madrigal and Myriad is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Myriad Genetics go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Myriad Genetics

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.68 times more return on investment than Myriad Genetics. However, Madrigal Pharmaceuticals is 1.68 times more volatile than Myriad Genetics. It trades about 0.12 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.1 per unit of risk. If you would invest  31,404  in Madrigal Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of  2,610  from holding Madrigal Pharmaceuticals or generate 8.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Myriad Genetics

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Madrigal Pharmaceuticals and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Myriad Genetics

The main advantage of trading using opposite Madrigal Pharmaceuticals and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind Madrigal Pharmaceuticals and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk